Swiss National Bank - PACIFIC BIOSCIENCES CALIF IN ownership

PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 131 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q3 2016. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of PACIFIC BIOSCIENCES CALIF IN
ValueSharesWeighting
Q3 2023$4,357,414
-36.6%
521,846
+1.0%
0.00%
-40.0%
Q2 2023$6,871,392
+28.0%
516,646
+11.4%
0.01%
+25.0%
Q1 2023$5,369,021
+27.3%
463,646
-10.1%
0.00%
+33.3%
Q4 2022$4,218,802
+43.8%
515,746
+2.0%
0.00%
+50.0%
Q3 2022$2,934,000
+34.0%
505,446
+2.0%
0.00%
+100.0%
Q2 2022$2,190,000
-51.4%
495,5460.0%0.00%
-66.7%
Q1 2022$4,509,000
-47.0%
495,546
+19.3%
0.00%
-40.0%
Q4 2021$8,502,000
-20.1%
415,546
-0.2%
0.01%
-28.6%
Q3 2021$10,640,000
-24.8%
416,446
+3.0%
0.01%
-22.2%
Q2 2021$14,140,000
+4.5%
404,346
-0.5%
0.01%0.0%
Q1 2021$13,535,000
+39.7%
406,346
+8.8%
0.01%
+28.6%
Q4 2020$9,690,000
+162.8%
373,5460.0%0.01%
+133.3%
Q3 2020$3,687,000
+247.5%
373,546
+21.5%
0.00%
+200.0%
Q2 2020$1,061,000
+37.4%
307,446
+21.9%
0.00%0.0%
Q1 2020$772,000
-39.6%
252,246
+1.4%
0.00%0.0%
Q4 2019$1,279,000
+1.8%
248,846
+2.1%
0.00%0.0%
Q3 2019$1,257,000
-13.1%
243,646
+2.0%
0.00%
-50.0%
Q2 2019$1,446,000
-18.1%
238,946
-2.2%
0.00%0.0%
Q1 2019$1,766,000
+2.7%
244,246
+5.1%
0.00%0.0%
Q4 2018$1,720,000
+41.8%
232,446
+3.7%
0.00%
+100.0%
Q3 2018$1,213,000
+78.6%
224,246
+17.3%
0.00%0.0%
Q2 2018$679,000
+73.2%
191,2460.0%0.00%
Q1 2018$392,000
-11.9%
191,246
+13.4%
0.00%
Q4 2017$445,000
-49.7%
168,6460.0%0.00%
-100.0%
Q3 2017$885,000
+47.5%
168,6460.0%0.00%0.0%
Q2 2017$600,000
-16.3%
168,646
+21.6%
0.00%0.0%
Q1 2017$717,000
+36.1%
138,6460.0%0.00%0.0%
Q4 2016$527,000
-57.6%
138,6460.0%0.00%
-50.0%
Q3 2016$1,242,000
+27.4%
138,6460.0%0.00%0.0%
Q2 2016$975,000
+9.9%
138,646
+28.3%
0.00%0.0%
Q1 2016$887,000
-20.0%
108,046
+27.9%
0.00%
-33.3%
Q4 2015$1,109,000
+356.4%
84,446
+27.0%
0.00%
+200.0%
Q3 2015$243,000
-27.5%
66,500
+14.3%
0.00%0.0%
Q2 2015$335,000
+19.6%
58,200
+21.2%
0.00%0.0%
Q1 2015$280,000
-25.5%
48,0000.0%0.00%0.0%
Q4 2014$376,00048,0000.00%
Other shareholders
PACIFIC BIOSCIENCES CALIF IN shareholders Q3 2016
NameSharesValueWeighting ↓
HAVENS ADVISORS LLC 611,500$3,700,0002.60%
Versor Investments LP 4,382,622$26,515,0001.77%
ORACLE INVESTMENT MANAGEMENT INC 1,110,666$6,720,0001.45%
SYQUANT CAPITAL SAS 712,227$4,309,0001.38%
HighVista Strategies LLC 378,479$2,290,0001.17%
Kite Lake Capital Management (UK) LLP 3,503,293$21,195,0001.11%
WATER ISLAND CAPITAL LLC 7,756,672$46,928,0001.09%
ALPINE ASSOCIATES MANAGEMENT INC. 6,080,059$36,784,0001.08%
Exane Asset Management 398,743$2,412,395,0001.07%
STANSBERRY ASSET MANAGEMENT, LLC 431,017$2,608,0001.03%
View complete list of PACIFIC BIOSCIENCES CALIF IN shareholders